Residual Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnoea treated with Continuous Positive Airway Pressure: A Meta-Analysis
作者
Ahmed Almaghrabi,Asim Madkhali,Mohammed Alkhathami,Cheng Zhang,Abdulaziz Alsharifi,Gerrard Francis Rafferty,Joerg S. Steier
出处
期刊:The European respiratory journal [European Respiratory Society] 日期:2025-09-27卷期号:: OA3306-OA3306
标识
DOI:10.1183/13993003.congress-2025.oa3306
摘要
Introduction: Obstructive Sleep Apnoea (OSA) is a common nocturnal breathing disorder, and continuous positive airway pressure (CPAP) is its primary treatment. However, some patients experience residual Excessive Daytime Sleepiness (EDS) despite acceptable CPAP adherence. We sought to assess residual EDS's prevalence in OSA treated with CPAP. Methods: We undertook a meta-analysis (PROSPERO database ID: CRD42024521385) to assess residual EDS in patients with OSA, defined as an Epworth Sleepiness Scale (ESS) >10 after >3 months of CPAP therapy. Standardised mean differences (SMD), risk ratio (RR), and 95% confidence intervals (CI) were computed using Review Manager (RevMan V.5.4.0). Study heterogeneity (I²) and quality were assessed. Results: We identified 6,310 articles across PubMed and Web of Science (until April 2024) published in English. After removing duplicates, screening titles, and abstracts, 98 full-text articles were assessed for eligibility. 5 studies met the criteria for meta-analysis, which included 5,186 participants (2,995 males; 52.2±11.6 years, body mass index BMI 34.1±7.0kg/m², baseline apnoea hypopnoea index AHI 43.4±26.2 x hour-1). ESS improved from 12.8±4.3 to 7.6±2.9 points (SMD -1.40, 95% CI -2.08 to -0.72, p<0.0001) with CPAP use of 4.8±2.0 hours/night. Residual EDS persisted in 27.0% of patients (RR:0.38). High heterogeneity was observed in residual EDS prevalence (I²=92%). Conclusion: CPAP significantly reduces EDS in OSA; however, 27% of patients with OSA sufficiently treated with CPAP continue to experience residual EDS. The high heterogeneity may, in parts, be related to varying degrees of treatment adherence.